No Picture
News

Caris Life Sciences and Incyte Enter Into Broad Precision Medicine Partnership to Advance Incyte’s Oncology Pipeline

IRVING, Texas, March 7, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, today announced a strategic research partnership with Incyte Corporation… […]

No Picture
News

NanOlogy Granted a US Patent for Its Investigational Drugs in Combination with Immune Checkpoint Inhibitors in the Treatment of Cancer

FORT WORTH, Texas–(BUSINESS WIRE)–Patent covers intratumoral delivery of certain LSAM investigational drugs with systemic Immune Checkpoint Inhibitors. Click here to view original post